HEALTHCARE is a great value right now

=== SUMMARY === - The author argues that the healthcare sector is currently undervalued and poised for significant growth due to an aging population and the integration of AI technologies. - The post highlights MMED as a specific value play based on a relative valuation comparison to DXCM, while also recommending broad healthcare ETFs for safer exposure. - Quality assessment: Speculation mixed with basic fundamental comparisons; lacks deep, rigorous due diligence but provides a clear macro thesis. === SENTIMENT === BULLISH === TRADE IDEAS === MMED - LONG | confidence: 0.85 | sentiment: +0.80 Speaker: u/Idntevncare Thesis: 1. THE FACT: MMED is a recent IPO with a $5B market cap, a 27 PE ratio, and $3.1B in revenue. 2. THE BRIDGE: Peer DXCM has a $31B market cap with only $1.5B more in revenue ($4.6B), highlighting a massive valuation gap. 3. THE VERDICT: MMED is significantly undervalued relative to its revenue and has the potential to double or triple in market cap. 4. RISKS: As a recent IPO, it may face volatility; execution risks in scaling operations to match larger peers. Timeframe: medium-term Key Points: - Recent IPO with $5B market cap. - Attractive PE ratio of 27. - Generates $3.1B in revenue. - Undervalued compared to DXCM. - Potential to reach $10B-$15B cap. XLV - LONG | confidence: 0.90 | sentiment: +0.75 Speaker: u/Idntevncare Thesis: 1. THE FACT: A massive generation is reaching an age where constant healthcare is a necessity. 2. THE BRIDGE: This demographic shift, combined with new AI tech, creates "guaranteed" growth for the sector over the next decade. 3. THE VERDICT: Broad healthcare ETFs (like XLV, VHT, IBB, IXJ) offer a safe, high-probability way to capture this macro trend. 4. RISKS: Political/regulatory changes to healthcare pricing; AI integration taking longer than expected to yield profits. Timeframe: long-term Key Points: - Sector recently experienced a dip. - Aging population guarantees demand. - AI integration provides massive upside. -